Anatomically, the primary tumor is in the duodenum but extends into the gastric pylorus. Would Zolbetuximab be reasonable to offer with FOLFOX, rather...
New answer by Medical Oncologist at NYU Grossman School of Medicine (February 7, 2025)
I agree with Dr. @Sonbol. These patients were not included in the reported studies, so they would be exposing patients to the risks (infusion reactions, GI upset as noted by D...